Keyphrases
Osteoporotic Fractures
100%
Myasthenia Gravis
100%
Oral Glucocorticoids
100%
Osteoporotic Fracture Risk
75%
Pooled Analysis
33%
Glucocorticoid Use
16%
Osteoporosis Prevention
16%
Comorbidity
8%
Odds Ratio
8%
Cumulative Dose
8%
Epidemiological Study
8%
Non-associated
8%
High Dose
8%
Co-medication
8%
Random Effects Model
8%
Population-based
8%
Variance Method
8%
Conditional Logistic Regression
8%
Clinical Practice Guidelines
8%
National Health Service
8%
Inverse Variance
8%
Patient-centered
8%
Prolonged Use
8%
Fracture Control
8%
Medicine and Dentistry
Fragility Fracture
100%
Glucocorticoid
100%
Myasthenia gravis
100%
Pooled Analysis
33%
Osteoporosis
16%
Logistic Regression Analysis
8%
Population Research
8%
Random Effects Model
8%
Drug Megadose
8%
Clinical Guideline
8%
National Health Service
8%
Comorbidity
8%
Odds Ratio
8%
Pharmacology, Toxicology and Pharmaceutical Science
Glucocorticoid
100%
Fragility Fracture
100%
Myasthenia gravis
100%
Population Study
8%
Random Effects Model
8%
Comorbidity
8%
Immunology and Microbiology
Myasthenia gravis
100%
Glucocorticoid
100%
Population Research
8%
Drug Megadose
8%
Comorbidity
8%
Biochemistry, Genetics and Molecular Biology
Glucocorticoid
100%
Population Research
9%
Drug Megadose
9%
Comorbidity
9%